Robinson Capital Management’s Envoy Medical COCH Stock Holding History

Robinson Capital Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85,400	Closed	-$891K	–	230
2023 Q3	$891K	Hold	85,400	–	–	0.4%	54
2023 Q2	$875K	Buy	85,400 +10,000	+13%	+$101K	0.39%	53
2023 Q1	$757K	Buy	75,400 +38,788	+106%	+$389K	0.35%	54
2022 Q4	$368K	Hold	36,612	–	–	0.19%	100
2022 Q3	$360K	Buy	36,612 +12,000	+49%	+$118K	0.29%	82
2022 Q2	$241K	Buy	24,612 +2,997	+14%	+$29.3K	0.18%	122
2022 Q1	$211K	Hold	21,615	–	–	0.14%	128
2021 Q4	$211K	Buy	21,615 +11,205	+108%	+$109K	0.13%	89
2021 Q3	$101K	Buy	+10,410	New	+$101K	0.09%	90

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Robinson Capital Management's COCH Position: Q4 2023 in Review

Robinson Capital Management sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 85,400 shares — an estimated $891K sold.

Robinson Capital Management first reported a position in COCH in Q3 2021 and held it in 9 quarters. The position peaked at $891K in Q3 2023. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

Robinson Capital Management reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
Robinson Capital Management sold 85,400 Envoy Medical shares in Q4 2023, an estimated $891K.
Robinson Capital Management first reported a position in Envoy Medical in Q3 2021 and held it in 9 quarters.
Robinson Capital Management's Envoy Medical position peaked at $891K in Q3 2023.
9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Robinson Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.